Literature DB >> 12702137

Cushing's syndrome in a patient treated by ritonavir/lopinavir and inhaled fluticasone.

I Rouanet, H Peyrière, J M Mauboussin, D Vincent.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12702137     DOI: 10.1046/j.1468-1293.2003.00149.x

Source DB:  PubMed          Journal:  HIV Med        ISSN: 1464-2662            Impact factor:   3.180


× No keyword cloud information.
  6 in total

1.  Therapeutic drug monitoring of atazanavir: surveillance of pharmacotherapy in the clinic.

Authors:  John E Ray; Debbie Marriott; Mark T Bloch; Andrew J McLachlan
Journal:  Br J Clin Pharmacol       Date:  2005-09       Impact factor: 4.335

2.  Influence of low-dose ritonavir with and without darunavir on the pharmacokinetics and pharmacodynamics of inhaled beclomethasone.

Authors:  Sarita D Boyd; Colleen Hadigan; Maryellen McManus; Cheryl Chairez; Lynnette K Nieman; Alice K Pau; Raul M Alfaro; Joseph A Kovacs; Monica M Calderon; Scott R Penzak
Journal:  J Acquir Immune Defic Syndr       Date:  2013-07-01       Impact factor: 3.731

Review 3.  Inhaled corticosteroid use in HIV-positive individuals taking protease inhibitors: a review of pharmacokinetics, case reports and clinical management.

Authors:  P Saberi; T Phengrasamy; D P Nguyen
Journal:  HIV Med       Date:  2013-04-16       Impact factor: 3.180

4.  Influence of antiretroviral drugs on the pharmacokinetics of prednisolone in HIV-infected individuals.

Authors:  Kristin H Busse; Elizabeth Formentini; Raul M Alfaro; Joseph A Kovacs; Scott R Penzak
Journal:  J Acquir Immune Defic Syndr       Date:  2008-08-15       Impact factor: 3.731

Review 5.  COVID-19 and the pituitary.

Authors:  Stefano Frara; Agnese Allora; Laura Castellino; Luigi di Filippo; Paola Loli; Andrea Giustina
Journal:  Pituitary       Date:  2021-05-03       Impact factor: 3.599

6.  Iatrogenic Cushing syndrome and adrenal insufficiency during concomitant therapy with ritonavir and fluticasone.

Authors:  Narendranath Epperla; Fergus McKiernan
Journal:  Springerplus       Date:  2015-08-27
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.